Cargando…
Therapeutic effect and rebound evaluation of dapagliflozin on glycated hemoglobin (HbA1c) in type 1 diabetes mellitus patients
Dapagliflozin has been used to treat patients with type 1 diabetes mellitus; however, the actual drug efficacy of dapagliflozin on glycated hemoglobin (HbA1c) and whether there is a rebound from dapagliflozin efficacy on HbA1c remain unknown. The present study aimed to explore the actual therapeutic...
Autores principales: | Wang, Dong-Dong, Zhang, Cun, Hu, Ke, He, Su-Mei, Zhu, Ping, Chen, Xiao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9845776/ https://www.ncbi.nlm.nih.gov/pubmed/36686651 http://dx.doi.org/10.3389/fphar.2022.972878 |
Ejemplares similares
-
Glycated Hemoglobin (HbA1c): Clinical Applications of a Mathematical Concept
por: Leow, Melvin Khee Shing
Publicado: (2016) -
Glycated Hemoglobin (HbA1c) as a Biomarker for Diabetic Foot Peripheral Neuropathy
por: Casadei, Giulia, et al.
Publicado: (2021) -
Relationship between Glycated Hemoglobin (HbA1c) in Adolescents with Type 1 Diabetes Mellitus (T1DM) and Parental Anxiety and Depression
por: Silina, E., et al.
Publicado: (2023) -
Glycated hemoglobin HbA(1c) – a new risk marker for the outcome of cardiac surgery?
por: Biskupski, Andrzej, et al.
Publicado: (2014) -
Hemoglobin variants detected by hemoglobin A1c (HbA1c) analysis and the effects on HbA1c measurements
por: Nasir, Nadzimah Mohd, et al.
Publicado: (2010)